专利检索 ap:("National University Corporation Tokyo Medical AND Dental University" OR "Cespia Inc.") AND inv:"NAKAMURA, Shun" 第 1 页

1.

发明公开
PEPTIDE HAVING ANTI-VIRAL ACTIVITY, ANTI-VIRAL AGENT COMPRISING SAID PEPTIDE, AND METHOD FOR PRODUCING SAID ANTI-VIRAL AGENT 审中-实审

公开(公告)号：EP4368631A1

公开(公告)日：2024-05-15

申请号：EP22837695.0

申请日：2022-07-06

申请人： National University Corporation Tokyo Medical and Dental University , Cespia Inc.

发明人： FUJIYOSHI, Yoshinori , NAKAMURA, Shun , NOMURA, Risa , TANIMURA, Yukihiro , KAMEGAWA, Akiko , NUMOTO, Nobutaka

IPC分类号： C07K14/00 , A61K9/08 , A61K38/10 , A61K38/16 , A61P31/14 , C07K7/08 , C12N7/06

CPC分类号： A61K9/08 , A61K38/10 , A61K38/16 , A61P31/14 , C07K7/08 , C07K14/00 , C12N7/06

摘要： Provided is a peptide capable of binding to a receptor binding domain (RBD) in SARS-CoV-2, chemically synthesized easily, having extremely high solubility to ultra-pure water or a buffer solution and a high possibility of being put to practical use as a therapeutic drug for COVID-19.